JAK inhibitor Momelotinib mesylate, Purity ≥98%

Cat. No.: X23-10-ZQ396

JAK inhibitor Momelotinib mesylate, Purity ≥98%

Synonym: momelotinib Mesylate; CYT387 Mesylate; 1056636-07-7; CYT387 (Mesylate); N-(Cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide; methanesulfonic acid; JAK inhibitor

  • CAS Number: 1056636-07-7
  • Compound CID: 78357762
Product Size
1 mg; 5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
Momelotinib mesylate is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, and JAK3.
Molecular Weight
510.57
Molecular Formula
C24H26N6O5S
Targets
JAK1: 11 nM; JAK2: 18 nM; JAK3: 155 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Momelotinib mesylate can be applied to research inhibition of JAK1 and JAK2 signaling.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.